Chorokbaem Healthcare Co Ltd (118000) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.007x

Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) has a cash flow conversion efficiency ratio of 0.007x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩980.30 Million ≈ $664.33K USD) by net assets (₩137.68 Billion ≈ $93.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Chorokbaem Healthcare Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Chorokbaem Healthcare Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Chorokbaem Healthcare Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chorokbaem Healthcare Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chorokbaem Healthcare Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Chorokbaem Healthcare Co Ltd to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Shape Robotics AS
CO:SHAPE
-0.213x
All In! Games S.A.
WAR:ALG
-0.028x
Horizon Petroleum Ltd
V:HPL
0.257x
Starbreeze AB (publ)
ST:STAR-B
-0.015x
Aurora Labs Ltd
AU:A3D
-1.442x
IntegraFin Holdings plc
LSE:IHP
1.676x
GiantStep Co. Ltd.
KQ:289220
-0.086x
DAVIDsTEA Inc
F:DAT
-0.114x

Annual Cash Flow Conversion Efficiency for Chorokbaem Healthcare Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Chorokbaem Healthcare Co Ltd from 2013 to 2025. View 118000 live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩120.98 Billion
≈ $81.99 Million
₩2.42 Billion
≈ $1.64 Million
0.020x -47.82%
2024-12-31 ₩116.80 Billion
≈ $79.15 Million
₩4.48 Billion
≈ $3.03 Million
0.038x +141.05%
2023-12-31 ₩137.70 Billion
≈ $93.32 Million
₩-12.86 Billion
≈ $-8.71 Million
-0.093x -378.38%
2022-12-31 ₩129.58 Billion
≈ $87.81 Million
₩-2.53 Billion
≈ $-1.71 Million
-0.020x -56.24%
2021-12-31 ₩119.40 Billion
≈ $80.92 Million
₩-1.49 Billion
≈ $-1.01 Million
-0.012x -125.06%
2020-12-31 ₩76.13 Billion
≈ $51.59 Million
₩3.79 Billion
≈ $2.57 Million
0.050x +43.90%
2019-12-31 ₩35.94 Billion
≈ $24.35 Million
₩1.24 Billion
≈ $843.66K
0.035x +123.68%
2018-12-31 ₩18.51 Billion
≈ $12.54 Million
₩-2.71 Billion
≈ $-1.84 Million
-0.146x +78.43%
2017-12-31 ₩18.71 Billion
≈ $12.68 Million
₩-12.69 Billion
≈ $-8.60 Million
-0.678x -87.81%
2016-12-31 ₩13.44 Billion
≈ $9.11 Million
₩-4.85 Billion
≈ $-3.29 Million
-0.361x +37.24%
2015-12-31 ₩6.19 Billion
≈ $4.19 Million
₩-3.56 Billion
≈ $-2.41 Million
-0.575x +8.39%
2014-12-31 ₩8.32 Billion
≈ $5.64 Million
₩-5.22 Billion
≈ $-3.54 Million
-0.628x -4003.37%
2013-12-31 ₩16.04 Billion
≈ $10.87 Million
₩258.12 Million
≈ $174.92K
0.016x --

About Chorokbaem Healthcare Co Ltd

KO:118000 Korea Drug Manufacturers - General
Market Cap
$14.98 Million
₩22.11 Billion KRW
Market Cap Rank
#26088 Global
#1957 in Korea
Share Price
₩1287.00
Change (1 day)
+1.58%
52-Week Range
₩222.00 - ₩2080.00
All Time High
₩13800.00
About

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more